CD14 and pancreatic exocrine neoplasm: As CAMLs have shown CD14 + , and are theorized to be myeloid origin based on their phagocytic macrophage-like nature18–20, it can be surmised that they may also recruit to these premalignant lesions in the course of progression to pancreatic exocrine tumors.